Micki Klearman SEC EDGAR Filings (CIK 0001864934)

SEC EDGAR filings, ownership reports, and insider transactions for Micki Klearman.

Business address
C/O Kezar Life Sciences, Inc., 4000 Shoreline Court, Suite 300, South San Francisco, CA, 94080
Get insider transactions for this reporting owner
Micki Klearman has filed 8 SEC EDGAR filings since 03 Jun 2021

Latest Filings

Recent SEC filings for Micki Klearman including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 23 Jun 2025 18 Jun 2025 001-38542
4 Open 4 document View SEC filing for 4 21 Jun 2024 20 Jun 2024 001-38542
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 26 Jul 2023 24 Jul 2023 001-38542
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 16 Jun 2023 15 Jun 2023 001-38542
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 17 Jun 2022 16 Jun 2022 001-38542
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 Jun 2021 28 Jun 2021 001-38542
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Jun 2021 01 Jun 2021 001-38542
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jun 2021 01 Jun 2021 001-38542

About this filer

Micki Klearman files with the SEC under CIK 0001864934. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages